AcroMetrix Coronavirus (COVID-19) Testing Control (RUO)

In an effort to help with the recent Coronavirus outbreak, Thermo Fisher Scientific has designed and developed the AcroMetrix™ Coronavirus 2019 (COVID-19) RNA Control (RUO),1 containing full length genomic RNA from SARS-CoV-2 to help labs validate and monitor COVID-19 molecular diagnostic tests. Taking FDA guidelines into account, the controls were carefully designed at two different concentrations, a low positive and an ultra-low positive control. Both the controls are quantitated using Bio-Rad™ Droplet Digital™ PCR (ddPCR™) technology.

Please complete the form below to learn more. A representative will contact you shortly.

1For Research Use Only.